in vivo experiments have revealed the role of SIGIRR as an anti-inflammatory agent, as SIGIRR (−/−) mice exhibited more severe disease in both zymosan-induced arthritis and collagen antibody-induced arthritis models (Ref. Here, SIGIRR is linked to arthritic joint disease.